Anavex Life Sciences Corp.

Bank of New York Mellon Corp AVXL

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

244,055

Value ($000)

869

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	869	0.0%	244,055	12/31/2025
2025 Q3	11/3/2025	2,207	0.0%	248,014	9/30/2025
2025 Q2	8/5/2025	2,134	0.0%	231,496	6/30/2025
2025 Q1	4/29/2025	1,914	0.0%	223,131	3/31/2025
2024 Q4	2/4/2025	2,365	0.0%	220,249	12/31/2024
2024 Q3	11/12/2024	1,278	0.0%	224,980	9/30/2024
2024 Q2	7/25/2024	1,184	0.0%	280,556	6/30/2024
2024 Q1	4/25/2024	1,220	0.0%	239,661	3/31/2024
2023 Q4	1/29/2024	2,384	0.0%	256,098	12/31/2023
2023 Q3	10/24/2023	1,688	0.0%	257,700	9/30/2023
2023 Q2	8/3/2023	2,087	0.0%	256,709	6/30/2023
2023 Q1	5/9/2023	2,181	0.0%	254,523	3/31/2023
2022 Q4	2/14/2023	2,301	0.0%	248,474	12/31/2022
2022 Q3	11/14/2022	2,558	0.0%	247,897	9/30/2022
2022 Q2	8/15/2022	2,183	0.0%	218,126	6/30/2022
2022 Q1	5/11/2022	2,790	0.0%	226,742	3/31/2022
2021 Q4	2/11/2022	3,913	0.0%	225,711	12/31/2021
2021 Q3	11/18/2021	3,904	0.0%	217,476	9/30/2021
2021 Q2	8/11/2021	5,970	0.0%	261,167	6/30/2021
2021 Q1	5/13/2021	3,062	0.0%	204,823	3/31/2021
2020 Q4	2/9/2021	1,048	0.0%	194,051	12/31/2020
2020 Q3	11/12/2020	745	0.0%	163,788	9/30/2020
2020 Q2	8/12/2020	803	0.0%	163,230	6/30/2020
2020 Q1	5/6/2020	505	0.0%	160,062	3/31/2020
2019 Q4	2/14/2020	368	0.0%	142,111	12/31/2019